GCG and infarction: Further to our recent observation that GLP-1 mediates distinct beneficial effects on post-infarction remodelling, the aim of this study was to specifically investigate whether metabolically-inactive GLP-1(9–36) also plays a key role in this setting, by employing a normoglycaemic experimental model to directly assess its cardioprotective contribution.